Steven Levy MD ( MD Stem Cells )

5 4 0 0

Stem Cell Ophthalmology Treatment Study releases data on ClinicalTrials.gov Website

Stem Cell Ophthalmology Treatment Study releases data on ClinicalTrials.gov Website

The Stem Cell Ophthalmology Treatment Study II or SCOTS 2 continues to publish results of the largest  stem cell study for eye disease ever conducted in peer-reviewed medical and scientific publications.   The quality of the journals is high with…

Steven Levy at MD Stem Cells tapped for Biological Information & Biomedical Engineering Conference

Steven Levy at MD Stem Cells tapped for Biological Information & Biomedical Engineering Conference

Steven Levy MD, CEO of MD Stem Cells and Study Director for several pivotal clinical studies using adult bone marrow derived stem cells is providing critical peer-review for  a major international medical and scientific conference to be held in Shanghai,…

Ushers Syndrome Improves with Stem Cell Treatment in SCOTS 2

Ushers Syndrome Improves with Stem Cell Treatment in SCOTS 2

MD Stem Cells' study called The Stem Cell Ophthalmology Treatment Study II or SCOTS 2 is showing promising results in a form of Retinitis Pigmentosa (RP) called Ushers Syndrome.         Ushers is the most common syndromic form…

New Spinal Cord Stem Cell Treatment combined with Exoskeleton and Virtual Reality

New Spinal Cord Stem Cell Treatment combined with Exoskeleton and Virtual Reality

Spinal cord injury recovery remains the 'Holy Grail' of regenerative medicine because many patients suffering spinal cord damage and paralysis are active people experiencing a life changing injury suddenly and without warning.  MD Stem Cells has recently obtained institutional review…

SCOTS- Eye Stem Cell Study Beats Research Goals

The Stem Cell Ophthalmology Treatment Study or SCOTS has exceeded its research contribution goals as reported in Research Gate- the premier professional network for scientists and researchers.  Currently Research Gate members have read articles provided by the SCOTS clinicians almost…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login